Thomas J. Galloway

6.8k total citations · 2 hit papers
95 papers, 2.4k citations indexed

About

Thomas J. Galloway is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas J. Galloway has authored 95 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Otorhinolaryngology, 38 papers in Oncology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas J. Galloway's work include Head and Neck Cancer Studies (56 papers), Cancer Diagnosis and Treatment (14 papers) and Advanced Radiotherapy Techniques (13 papers). Thomas J. Galloway is often cited by papers focused on Head and Neck Cancer Studies (56 papers), Cancer Diagnosis and Treatment (14 papers) and Advanced Radiotherapy Techniques (13 papers). Thomas J. Galloway collaborates with scholars based in United States, Canada and Japan. Thomas J. Galloway's co-authors include John A. Ridge, Ranee Mehra, Elizabeth A. Handorf, Colin T. Murphy, Douglas B. Flieder, Barbara Burtness, Miriam N. Lango, Brian L. Egleston, Lora S. Wang and Jeffrey Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Thomas J. Galloway

90 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

2014 330 citations Phuc Félix Nguyen‐Tan, David I. Rosenthal et al. profile →
Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States

2015 298 citations Colin T. Murphy, Thomas J. Galloway et al. profile →

Peers

Countries citing papers authored by Thomas J. Galloway

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Galloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Galloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Galloway more than expected).

Fields of papers citing papers by Thomas J. Galloway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Galloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Galloway. The network helps show where Thomas J. Galloway may publish in the future.

Co-authorship network of co-authors of Thomas J. Galloway

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Galloway. A scholar is included among the top collaborators of Thomas J. Galloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Galloway. Thomas J. Galloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Computed Tomography-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors: A Retrospective Study 2025 ·International Journal of Radiation OncologyBiologyPhysics ·Alexander Lukez, Zhang Li, Eric M. Horwitz, Thomas J. Galloway, M.A. Hallman, Johnny Wong, Sameera Kumar, (unknown), Chang‐Ming Charlie, (unknown), (unknown), (unknown), Robert G. Freeman, Joshua E. Meyer	1
2	Long-Term Feeding Tube Use in Head and Neck Cancer Survivors—An Analysis of Patient- and Treatment-Related Factors 2025 ·International Journal of Radiation OncologyBiologyPhysics ·Thomas J. Galloway, Stephanie L. Pugh, John A. Ridge, Phuc Félix Nguyen‐Tan, David I. Rosenthal, Maura L. Gillison, Adam S. Garden, Neal Dunlap, Jimmy J. Caudell, Christopher U. Jones, Jessica R. Bauman, Houda Bahig, George Shenouda, Adam Currey, (unknown), William A. Stokes, Nancy Read, Jeffrey M. Lyness, Sue S. Yom, Quynh‐Thu Le	0
3	Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer 2023 ·Cancer Reports ·Brian L. Egleston, Richard J. Bleicher, Carolyn Y. Fang, Thomas J. Galloway, Slobodan Vučetić	4
4	Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Matthew C. Ward, Shlomo A. Koyfman, Richard L. Bakst, Danielle N. Margalit, Beth M. Beadle, Jonathan J. Beitler, Steven S. Chang, Jay S. Cooper, Thomas J. Galloway, John A. Ridge, Jared R. Robbins, Assuntina G. Sacco, C. Jillian Tsai, Sue S. Yom, Farzan Siddiqui	27
5	Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints 2022 ·Radiotherapy and Oncology ·Charles T. Lee, (unknown), Christopher M. K. L. Yao, Jeffrey Liu, John A. Ridge, Thomas J. Galloway	7
6	Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication 2020 ·Clinical Cancer Research ·Jared Weiss, Siddharth Sheth, Allison M. Deal, Juneko E. Grilley‐Olson, Samip Patel, Trevor Hackman, Jeffrey M. Blumberg, Thomas J. Galloway, Shetal Patel, Adam M. Zanation, Colette J. Shen, D. Neil Hayes, Christopher Hilliard, Ranee Mehra, Karen P. McKinnon, Hsing‐Hui Wang, Mark C. Weissler, Jessica R. Bauman, Bhishamjit S. Chera, Benjamin G. Vincent	29
7	Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary 2020 ·Head & Neck ·C. Jillian Tsai, Thomas J. Galloway, Danielle N. Margalit, Richard L. Bakst, Beth M. Beadle, Jonathan J. Beitler, Steven Chang, Allen M. Chen, Jay S. Cooper, Shlomo A. Koyfman, John A. Ridge, Jared R. Robbins, Minh Tam Truong, Sue S. Yom, Farzan Siddiqui	21
8	Examining adjuvant radiation dose in head and neck squamous cell carcinoma 2019 ·Head & Neck ·Vladimir Avkshtol, Elizabeth A. Handorf, John A. Ridge, (unknown), Jeffrey Liu, Jessica R. Bauman, Thomas J. Galloway	8
9	Impact of primary tumor‐specific growth rate on treatment failure for nonoropharyngeal head and neck cancers 2019 ·The Laryngoscope ·(unknown), (unknown), (unknown), (unknown), Thomas M. Churilla, Miriam N. Lango, Thomas J. Galloway	3
10	Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer 2019 ·Oral Oncology ·Yanqun Dong, John A. Ridge, Barbara Ebersole, Tianyu Li, Miriam N. Lango, Thomas M. Churilla, (unknown), Jessica R. Bauman, Thomas J. Galloway	33
11	Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis 2018 ·Radiotherapy and Oncology ·Nicholas G. Zaorsky, Charles T. Lee, (unknown), Thomas J. Galloway	34
12	Patterns of Initial Therapy for Larynx Cancer in Elderly Patients: A Population Based Analysis 2017 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), T.M. Churilla, Jessica R. Bauman, Miriam N. Lango, Brian L. Egleston, Thomas J. Galloway	1
13	Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis 2017 ·Radiotherapy and Oncology ·Nicholas G. Zaorsky, Charles T. Lee, (unknown), Scott W. Keith, Thomas J. Galloway	42
14	Local Control and Toxicity of External Beam Reirradiation With a Pulsed Low-dose-rate Technique 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Charles T. Lee, Yanqun Dong, Tianyu Li, (unknown), Jordan Anaokar, Thomas J. Galloway, M.A. Hallman, Stephanie E. Weiss, S.B. Hayes, R Price, C.‐M. Charlie, Joshua E. Meyer	9
15	Long-Term Toxicities in Survivors of Radiation Treatment for Head and Neck Cancer 2016 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), T.M. Churilla, Ranee Mehra, Miriam N. Lango, Jessica R. Bauman, John A. Ridge, Thomas J. Galloway	0
16	The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Talha Shaikh, Elizabeth A. Handorf, Colin T. Murphy, Ranee Mehra, John A. Ridge, Thomas J. Galloway	82
17	A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma 2015 ·Clinical Cancer Research ·Thomas J. Galloway, Lori J. Wirth, A. D. Colevas, Jill Gilbert, Julie E. Bauman, Nabil F. Saba, David Raben, Ranee Mehra, Anna Walaszczyk, Ruzanna Atoyan, Jing Wang, Barbara Burtness, Antonio Jimeno	84
18	Medical Communication-related Informational Need and Resource Preferences Among Family Caregivers for Head and Neck Cancer Patients 2015 ·Journal of Cancer Education ·Margaret L. Longacre, Thomas J. Galloway, Claudia Parvanta, Carolyn Y. Fang	41
19	Unilateral neck therapy in the human papillomavirus ERA: Accepted regional spread patterns 2012 ·Head & Neck ·Thomas J. Galloway, Miriam N. Lango, Barbara Burtness, Ranee Mehra, Karen Ruth, John A. Ridge	10
20	Revisiting unnecessary larynx irradiation with whole-neck IMRT 2011 ·Practical Radiation Oncology ·Thomas J. Galloway, Robert J. Amdur, Chihray Liu, Anamaria R. Yeung, William M. Mendenhall	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact